SIAG
PFE icon

Signet Investment Advisory Group’s Pfizer PFE Stock Holding History

Signet Investment Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.35M Buy
154,765
+5,465
+4% +$145K 1.99% 19
2025
Q4 		$3.72M Buy
149,300
+2,421
+2% +$61.1K 1.73% 23
2025
Q3 		$3.74M Buy
146,879
+11,567
+9% +$285K 1.8% 23
2025
Q2 		$3.28M Buy
135,312
+3,194
+2% +$74.5K 1.68% 23
2025
Q1 		$3.35M Buy
132,118
+8,932
+7% +$234K 1.69% 22
2024
Q4 		$3.27M Buy
123,186
+4,152
+3% +$113K 1.67% 23
2024
Q3 		$3.44M Buy
119,034
+2,507
+2% +$73.1K 1.72% 21
2024
Q2 		$3.26M Buy
116,527
+3,915
+3% +$108K 1.75% 20
2024
Q1 		$3.12M Buy
112,612
+6,500
+6% +$180K 1.71% 22
2023
Q4 		$3.05M Buy
106,112
+4,045
+4% +$122K 1.84% 18
2023
Q3 		$3.39M Buy
102,067
+2,260
+2% +$79.9K 2.25% 15
2023
Q2 		$3.66M Buy
99,807
+1,344
+1% +$52.3K 2.42% 12
2023
Q1 		$4.02M Buy
98,463
+8,196
+9% +$354K 2.77% 7
2022
Q4 		$4.63M Sell
90,267
-593
-0.7% -$28.4K 3.26% 6
2022
Q3 		$3.98M Buy
90,860
+386
+0.4% +$18.8K 3.08% 7
2022
Q2 		$4.74M Sell
90,474
-1,869
-2% -$95.2K 3.29% 6
2022
Q1 		$4.78M Sell
92,343
-2,535
-3% -$132K 2.87% 6
2021
Q4 		$5.6M Buy
94,878
+22
+0% +$1.09K 3.19% 6
2021
Q3 		$4.08M Buy
94,856
+4,504
+5% +$200K 2.57% 8
2021
Q2 		$3.54M Buy
90,352
+5,703
+7% +$222K 2.28% 10
2021
Q1 		$3.07M Buy
84,649
+2,411
+3% +$85.6K 2.38% 12
2020
Q4 		$3.03M Buy
+82,238
New +$3.02M 2.39% 11
2019
Q4 		$2.45M Buy
65,946
+480
+0.7% +$17.1K 2.28% 14
2019
Q3 		$2.23M Sell
65,466
-1,459
-2% -$53.1K 2.27% 16
2019
Q2 		$2.75M Sell
66,925
-3,316
-5% -$132K 2.87% 9
2019
Q1 		$2.83M Sell
70,241
-372
-0.5% -$14.9K 3.01% 7
2018
Q4 		$2.92M Buy
+70,613
New +$2.93M 3.28% 6

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Signet Investment Advisory Group's PFE Position: Q1 2026 in Review

Signet Investment Advisory Group increased its Pfizer (PFE) stake by 3.7% in Q1 2026, buying an estimated $145K and bringing the position to 154,765 shares worth $4.35M. The position accounts for 1.99% of the portfolio, ranked #19.

Signet Investment Advisory Group first reported a position in PFE in Q4 2018 and has held it in 27 quarters since. The position peaked at $5.6M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Signet Investment Advisory Group held 154,765 shares of Pfizer worth $4.35M as of Q1 2026.
  • Signet Investment Advisory Group bought 5,465 Pfizer shares in Q1 2026, an estimated $145K.
  • Pfizer made up 1.99% of Signet Investment Advisory Group's portfolio in Q1 2026, its #19 holding.
  • Signet Investment Advisory Group first reported a position in Pfizer in Q4 2018 and has held it in 27 quarters since.
  • Signet Investment Advisory Group's Pfizer position peaked at $5.6M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Signet Investment Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.